Global Etoricoxib Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
LPI (LP Information)' newest research report, the “Etoricoxib Industry Forecast” looks at past sales and reviews total world Etoricoxib sales in 2022, providing a comprehensive analysis by region and market sector of projected Etoricoxib sales for 2023 through 2029. With Etoricoxib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etoricoxib industry.
This Insight Report provides a comprehensive analysis of the global Etoricoxib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etoricoxib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Etoricoxib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etoricoxib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etoricoxib.
The global Etoricoxib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Etoricoxib players cover Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Etoricoxib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Etoricoxib market?
What factors are driving Etoricoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Etoricoxib market opportunities vary by end market size?
How does Etoricoxib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
LPI (LP Information)' newest research report, the “Etoricoxib Industry Forecast” looks at past sales and reviews total world Etoricoxib sales in 2022, providing a comprehensive analysis by region and market sector of projected Etoricoxib sales for 2023 through 2029. With Etoricoxib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etoricoxib industry.
This Insight Report provides a comprehensive analysis of the global Etoricoxib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etoricoxib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Etoricoxib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etoricoxib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etoricoxib.
The global Etoricoxib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Etoricoxib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Etoricoxib players cover Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Etoricoxib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 30 mg
- 60 mg
- 90 mg
- 120 mg
- Hospital
- Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Morepen Laboratories
- Merck & Co
- Frosst Iberica SA
- Metrochem API
- Atom Pharma
- Hema Pharmaceuticals
- Beijing Tide Pharmaceutical
- Qilu Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Easton Biopharmaceuticals
What is the 10-year outlook for the global Etoricoxib market?
What factors are driving Etoricoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Etoricoxib market opportunities vary by end market size?
How does Etoricoxib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Etoricoxib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Etoricoxib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Etoricoxib by Country/Region, 2018, 2022 & 2029
2.2 Etoricoxib Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 90 mg
2.2.4 120 mg
2.3 Etoricoxib Sales by Type
2.3.1 Global Etoricoxib Sales Market Share by Type (2018-2023)
2.3.2 Global Etoricoxib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Etoricoxib Sale Price by Type (2018-2023)
2.4 Etoricoxib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Others
2.5 Etoricoxib Sales by Application
2.5.1 Global Etoricoxib Sale Market Share by Application (2018-2023)
2.5.2 Global Etoricoxib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Etoricoxib Sale Price by Application (2018-2023)
3 GLOBAL ETORICOXIB BY COMPANY
3.1 Global Etoricoxib Breakdown Data by Company
3.1.1 Global Etoricoxib Annual Sales by Company (2018-2023)
3.1.2 Global Etoricoxib Sales Market Share by Company (2018-2023)
3.2 Global Etoricoxib Annual Revenue by Company (2018-2023)
3.2.1 Global Etoricoxib Revenue by Company (2018-2023)
3.2.2 Global Etoricoxib Revenue Market Share by Company (2018-2023)
3.3 Global Etoricoxib Sale Price by Company
3.4 Key Manufacturers Etoricoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etoricoxib Product Location Distribution
3.4.2 Players Etoricoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ETORICOXIB BY GEOGRAPHIC REGION
4.1 World Historic Etoricoxib Market Size by Geographic Region (2018-2023)
4.1.1 Global Etoricoxib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Etoricoxib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Etoricoxib Market Size by Country/Region (2018-2023)
4.2.1 Global Etoricoxib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Etoricoxib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Etoricoxib Sales Growth
4.4 APAC Etoricoxib Sales Growth
4.5 Europe Etoricoxib Sales Growth
4.6 Middle East & Africa Etoricoxib Sales Growth
5 AMERICAS
5.1 Americas Etoricoxib Sales by Country
5.1.1 Americas Etoricoxib Sales by Country (2018-2023)
5.1.2 Americas Etoricoxib Revenue by Country (2018-2023)
5.2 Americas Etoricoxib Sales by Type
5.3 Americas Etoricoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etoricoxib Sales by Region
6.1.1 APAC Etoricoxib Sales by Region (2018-2023)
6.1.2 APAC Etoricoxib Revenue by Region (2018-2023)
6.2 APAC Etoricoxib Sales by Type
6.3 APAC Etoricoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Etoricoxib by Country
7.1.1 Europe Etoricoxib Sales by Country (2018-2023)
7.1.2 Europe Etoricoxib Revenue by Country (2018-2023)
7.2 Europe Etoricoxib Sales by Type
7.3 Europe Etoricoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Etoricoxib by Country
8.1.1 Middle East & Africa Etoricoxib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Etoricoxib Revenue by Country (2018-2023)
8.2 Middle East & Africa Etoricoxib Sales by Type
8.3 Middle East & Africa Etoricoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etoricoxib
10.3 Manufacturing Process Analysis of Etoricoxib
10.4 Industry Chain Structure of Etoricoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etoricoxib Distributors
11.3 Etoricoxib Customer
12 WORLD FORECAST REVIEW FOR ETORICOXIB BY GEOGRAPHIC REGION
12.1 Global Etoricoxib Market Size Forecast by Region
12.1.1 Global Etoricoxib Forecast by Region (2024-2029)
12.1.2 Global Etoricoxib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Etoricoxib Forecast by Type
12.7 Global Etoricoxib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Etoricoxib Product Portfolios and Specifications
13.1.3 Morepen Laboratories Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Etoricoxib Product Portfolios and Specifications
13.2.3 Merck & Co Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Frosst Iberica SA
13.3.1 Frosst Iberica SA Company Information
13.3.2 Frosst Iberica SA Etoricoxib Product Portfolios and Specifications
13.3.3 Frosst Iberica SA Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Frosst Iberica SA Main Business Overview
13.3.5 Frosst Iberica SA Latest Developments
13.4 Metrochem API
13.4.1 Metrochem API Company Information
13.4.2 Metrochem API Etoricoxib Product Portfolios and Specifications
13.4.3 Metrochem API Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metrochem API Main Business Overview
13.4.5 Metrochem API Latest Developments
13.5 Atom Pharma
13.5.1 Atom Pharma Company Information
13.5.2 Atom Pharma Etoricoxib Product Portfolios and Specifications
13.5.3 Atom Pharma Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Atom Pharma Main Business Overview
13.5.5 Atom Pharma Latest Developments
13.6 Hema Pharmaceuticals
13.6.1 Hema Pharmaceuticals Company Information
13.6.2 Hema Pharmaceuticals Etoricoxib Product Portfolios and Specifications
13.6.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hema Pharmaceuticals Main Business Overview
13.6.5 Hema Pharmaceuticals Latest Developments
13.7 Beijing Tide Pharmaceutical
13.7.1 Beijing Tide Pharmaceutical Company Information
13.7.2 Beijing Tide Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.7.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Beijing Tide Pharmaceutical Main Business Overview
13.7.5 Beijing Tide Pharmaceutical Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Shanghai Shyndec Pharmaceutical
13.9.1 Shanghai Shyndec Pharmaceutical Company Information
13.9.2 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.10 Easton Biopharmaceuticals
13.10.1 Easton Biopharmaceuticals Company Information
13.10.2 Easton Biopharmaceuticals Etoricoxib Product Portfolios and Specifications
13.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Easton Biopharmaceuticals Main Business Overview
13.10.5 Easton Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Etoricoxib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Etoricoxib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Etoricoxib by Country/Region, 2018, 2022 & 2029
2.2 Etoricoxib Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 90 mg
2.2.4 120 mg
2.3 Etoricoxib Sales by Type
2.3.1 Global Etoricoxib Sales Market Share by Type (2018-2023)
2.3.2 Global Etoricoxib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Etoricoxib Sale Price by Type (2018-2023)
2.4 Etoricoxib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Others
2.5 Etoricoxib Sales by Application
2.5.1 Global Etoricoxib Sale Market Share by Application (2018-2023)
2.5.2 Global Etoricoxib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Etoricoxib Sale Price by Application (2018-2023)
3 GLOBAL ETORICOXIB BY COMPANY
3.1 Global Etoricoxib Breakdown Data by Company
3.1.1 Global Etoricoxib Annual Sales by Company (2018-2023)
3.1.2 Global Etoricoxib Sales Market Share by Company (2018-2023)
3.2 Global Etoricoxib Annual Revenue by Company (2018-2023)
3.2.1 Global Etoricoxib Revenue by Company (2018-2023)
3.2.2 Global Etoricoxib Revenue Market Share by Company (2018-2023)
3.3 Global Etoricoxib Sale Price by Company
3.4 Key Manufacturers Etoricoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etoricoxib Product Location Distribution
3.4.2 Players Etoricoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ETORICOXIB BY GEOGRAPHIC REGION
4.1 World Historic Etoricoxib Market Size by Geographic Region (2018-2023)
4.1.1 Global Etoricoxib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Etoricoxib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Etoricoxib Market Size by Country/Region (2018-2023)
4.2.1 Global Etoricoxib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Etoricoxib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Etoricoxib Sales Growth
4.4 APAC Etoricoxib Sales Growth
4.5 Europe Etoricoxib Sales Growth
4.6 Middle East & Africa Etoricoxib Sales Growth
5 AMERICAS
5.1 Americas Etoricoxib Sales by Country
5.1.1 Americas Etoricoxib Sales by Country (2018-2023)
5.1.2 Americas Etoricoxib Revenue by Country (2018-2023)
5.2 Americas Etoricoxib Sales by Type
5.3 Americas Etoricoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etoricoxib Sales by Region
6.1.1 APAC Etoricoxib Sales by Region (2018-2023)
6.1.2 APAC Etoricoxib Revenue by Region (2018-2023)
6.2 APAC Etoricoxib Sales by Type
6.3 APAC Etoricoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Etoricoxib by Country
7.1.1 Europe Etoricoxib Sales by Country (2018-2023)
7.1.2 Europe Etoricoxib Revenue by Country (2018-2023)
7.2 Europe Etoricoxib Sales by Type
7.3 Europe Etoricoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Etoricoxib by Country
8.1.1 Middle East & Africa Etoricoxib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Etoricoxib Revenue by Country (2018-2023)
8.2 Middle East & Africa Etoricoxib Sales by Type
8.3 Middle East & Africa Etoricoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etoricoxib
10.3 Manufacturing Process Analysis of Etoricoxib
10.4 Industry Chain Structure of Etoricoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etoricoxib Distributors
11.3 Etoricoxib Customer
12 WORLD FORECAST REVIEW FOR ETORICOXIB BY GEOGRAPHIC REGION
12.1 Global Etoricoxib Market Size Forecast by Region
12.1.1 Global Etoricoxib Forecast by Region (2024-2029)
12.1.2 Global Etoricoxib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Etoricoxib Forecast by Type
12.7 Global Etoricoxib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Etoricoxib Product Portfolios and Specifications
13.1.3 Morepen Laboratories Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Etoricoxib Product Portfolios and Specifications
13.2.3 Merck & Co Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Frosst Iberica SA
13.3.1 Frosst Iberica SA Company Information
13.3.2 Frosst Iberica SA Etoricoxib Product Portfolios and Specifications
13.3.3 Frosst Iberica SA Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Frosst Iberica SA Main Business Overview
13.3.5 Frosst Iberica SA Latest Developments
13.4 Metrochem API
13.4.1 Metrochem API Company Information
13.4.2 Metrochem API Etoricoxib Product Portfolios and Specifications
13.4.3 Metrochem API Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metrochem API Main Business Overview
13.4.5 Metrochem API Latest Developments
13.5 Atom Pharma
13.5.1 Atom Pharma Company Information
13.5.2 Atom Pharma Etoricoxib Product Portfolios and Specifications
13.5.3 Atom Pharma Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Atom Pharma Main Business Overview
13.5.5 Atom Pharma Latest Developments
13.6 Hema Pharmaceuticals
13.6.1 Hema Pharmaceuticals Company Information
13.6.2 Hema Pharmaceuticals Etoricoxib Product Portfolios and Specifications
13.6.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hema Pharmaceuticals Main Business Overview
13.6.5 Hema Pharmaceuticals Latest Developments
13.7 Beijing Tide Pharmaceutical
13.7.1 Beijing Tide Pharmaceutical Company Information
13.7.2 Beijing Tide Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.7.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Beijing Tide Pharmaceutical Main Business Overview
13.7.5 Beijing Tide Pharmaceutical Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Shanghai Shyndec Pharmaceutical
13.9.1 Shanghai Shyndec Pharmaceutical Company Information
13.9.2 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolios and Specifications
13.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.10 Easton Biopharmaceuticals
13.10.1 Easton Biopharmaceuticals Company Information
13.10.2 Easton Biopharmaceuticals Etoricoxib Product Portfolios and Specifications
13.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Easton Biopharmaceuticals Main Business Overview
13.10.5 Easton Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Etoricoxib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Etoricoxib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of 90 mg
Table 6. Major Players of 120 mg
Table 7. Global Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 8. Global Etoricoxib Sales Market Share by Type (2018-2023)
Table 9. Global Etoricoxib Revenue by Type (2018-2023) & ($ million)
Table 10. Global Etoricoxib Revenue Market Share by Type (2018-2023)
Table 11. Global Etoricoxib Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 13. Global Etoricoxib Sales Market Share by Application (2018-2023)
Table 14. Global Etoricoxib Revenue by Application (2018-2023)
Table 15. Global Etoricoxib Revenue Market Share by Application (2018-2023)
Table 16. Global Etoricoxib Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Etoricoxib Sales by Company (2018-2023) & (K Units)
Table 18. Global Etoricoxib Sales Market Share by Company (2018-2023)
Table 19. Global Etoricoxib Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Etoricoxib Revenue Market Share by Company (2018-2023)
Table 21. Global Etoricoxib Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Etoricoxib Producing Area Distribution and Sales Area
Table 23. Players Etoricoxib Products Offered
Table 24. Etoricoxib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Etoricoxib Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Etoricoxib Sales Market Share Geographic Region (2018-2023)
Table 29. Global Etoricoxib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Etoricoxib Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Etoricoxib Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Etoricoxib Sales Market Share by Country/Region (2018-2023)
Table 33. Global Etoricoxib Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Etoricoxib Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 36. Americas Etoricoxib Sales Market Share by Country (2018-2023)
Table 37. Americas Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Etoricoxib Revenue Market Share by Country (2018-2023)
Table 39. Americas Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 40. Americas Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 41. APAC Etoricoxib Sales by Region (2018-2023) & (K Units)
Table 42. APAC Etoricoxib Sales Market Share by Region (2018-2023)
Table 43. APAC Etoricoxib Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Etoricoxib Revenue Market Share by Region (2018-2023)
Table 45. APAC Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 46. APAC Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 47. Europe Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 48. Europe Etoricoxib Sales Market Share by Country (2018-2023)
Table 49. Europe Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Etoricoxib Revenue Market Share by Country (2018-2023)
Table 51. Europe Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 52. Europe Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Etoricoxib Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Etoricoxib Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Etoricoxib
Table 60. Key Market Challenges & Risks of Etoricoxib
Table 61. Key Industry Trends of Etoricoxib
Table 62. Etoricoxib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Etoricoxib Distributors List
Table 65. Etoricoxib Customer List
Table 66. Global Etoricoxib Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Etoricoxib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Etoricoxib Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Etoricoxib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Etoricoxib Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Etoricoxib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Etoricoxib Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Etoricoxib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Morepen Laboratories Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Morepen Laboratories Etoricoxib Product Portfolios and Specifications
Table 82. Morepen Laboratories Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Morepen Laboratories Main Business
Table 84. Morepen Laboratories Latest Developments
Table 85. Merck & Co Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck & Co Etoricoxib Product Portfolios and Specifications
Table 87. Merck & Co Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merck & Co Main Business
Table 89. Merck & Co Latest Developments
Table 90. Frosst Iberica SA Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Frosst Iberica SA Etoricoxib Product Portfolios and Specifications
Table 92. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Frosst Iberica SA Main Business
Table 94. Frosst Iberica SA Latest Developments
Table 95. Metrochem API Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Metrochem API Etoricoxib Product Portfolios and Specifications
Table 97. Metrochem API Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Metrochem API Main Business
Table 99. Metrochem API Latest Developments
Table 100. Atom Pharma Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 101. Atom Pharma Etoricoxib Product Portfolios and Specifications
Table 102. Atom Pharma Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Atom Pharma Main Business
Table 104. Atom Pharma Latest Developments
Table 105. Hema Pharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 106. Hema Pharmaceuticals Etoricoxib Product Portfolios and Specifications
Table 107. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Hema Pharmaceuticals Main Business
Table 109. Hema Pharmaceuticals Latest Developments
Table 110. Beijing Tide Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 111. Beijing Tide Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 112. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Beijing Tide Pharmaceutical Main Business
Table 114. Beijing Tide Pharmaceutical Latest Developments
Table 115. Qilu Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 116. Qilu Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 117. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Qilu Pharmaceutical Main Business
Table 119. Qilu Pharmaceutical Latest Developments
Table 120. Shanghai Shyndec Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 122. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shanghai Shyndec Pharmaceutical Main Business
Table 124. Shanghai Shyndec Pharmaceutical Latest Developments
Table 125. Easton Biopharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 126. Easton Biopharmaceuticals Etoricoxib Product Portfolios and Specifications
Table 127. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Easton Biopharmaceuticals Main Business
Table 129. Easton Biopharmaceuticals Latest Developments
Table 1. Etoricoxib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Etoricoxib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of 90 mg
Table 6. Major Players of 120 mg
Table 7. Global Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 8. Global Etoricoxib Sales Market Share by Type (2018-2023)
Table 9. Global Etoricoxib Revenue by Type (2018-2023) & ($ million)
Table 10. Global Etoricoxib Revenue Market Share by Type (2018-2023)
Table 11. Global Etoricoxib Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 13. Global Etoricoxib Sales Market Share by Application (2018-2023)
Table 14. Global Etoricoxib Revenue by Application (2018-2023)
Table 15. Global Etoricoxib Revenue Market Share by Application (2018-2023)
Table 16. Global Etoricoxib Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Etoricoxib Sales by Company (2018-2023) & (K Units)
Table 18. Global Etoricoxib Sales Market Share by Company (2018-2023)
Table 19. Global Etoricoxib Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Etoricoxib Revenue Market Share by Company (2018-2023)
Table 21. Global Etoricoxib Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Etoricoxib Producing Area Distribution and Sales Area
Table 23. Players Etoricoxib Products Offered
Table 24. Etoricoxib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Etoricoxib Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Etoricoxib Sales Market Share Geographic Region (2018-2023)
Table 29. Global Etoricoxib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Etoricoxib Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Etoricoxib Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Etoricoxib Sales Market Share by Country/Region (2018-2023)
Table 33. Global Etoricoxib Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Etoricoxib Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 36. Americas Etoricoxib Sales Market Share by Country (2018-2023)
Table 37. Americas Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Etoricoxib Revenue Market Share by Country (2018-2023)
Table 39. Americas Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 40. Americas Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 41. APAC Etoricoxib Sales by Region (2018-2023) & (K Units)
Table 42. APAC Etoricoxib Sales Market Share by Region (2018-2023)
Table 43. APAC Etoricoxib Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Etoricoxib Revenue Market Share by Region (2018-2023)
Table 45. APAC Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 46. APAC Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 47. Europe Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 48. Europe Etoricoxib Sales Market Share by Country (2018-2023)
Table 49. Europe Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Etoricoxib Revenue Market Share by Country (2018-2023)
Table 51. Europe Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 52. Europe Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Etoricoxib Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Etoricoxib Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Etoricoxib Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Etoricoxib Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Etoricoxib Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Etoricoxib Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Etoricoxib
Table 60. Key Market Challenges & Risks of Etoricoxib
Table 61. Key Industry Trends of Etoricoxib
Table 62. Etoricoxib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Etoricoxib Distributors List
Table 65. Etoricoxib Customer List
Table 66. Global Etoricoxib Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Etoricoxib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Etoricoxib Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Etoricoxib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Etoricoxib Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Etoricoxib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Etoricoxib Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Etoricoxib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Etoricoxib Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Etoricoxib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Morepen Laboratories Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Morepen Laboratories Etoricoxib Product Portfolios and Specifications
Table 82. Morepen Laboratories Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Morepen Laboratories Main Business
Table 84. Morepen Laboratories Latest Developments
Table 85. Merck & Co Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck & Co Etoricoxib Product Portfolios and Specifications
Table 87. Merck & Co Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merck & Co Main Business
Table 89. Merck & Co Latest Developments
Table 90. Frosst Iberica SA Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Frosst Iberica SA Etoricoxib Product Portfolios and Specifications
Table 92. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Frosst Iberica SA Main Business
Table 94. Frosst Iberica SA Latest Developments
Table 95. Metrochem API Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Metrochem API Etoricoxib Product Portfolios and Specifications
Table 97. Metrochem API Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Metrochem API Main Business
Table 99. Metrochem API Latest Developments
Table 100. Atom Pharma Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 101. Atom Pharma Etoricoxib Product Portfolios and Specifications
Table 102. Atom Pharma Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Atom Pharma Main Business
Table 104. Atom Pharma Latest Developments
Table 105. Hema Pharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 106. Hema Pharmaceuticals Etoricoxib Product Portfolios and Specifications
Table 107. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Hema Pharmaceuticals Main Business
Table 109. Hema Pharmaceuticals Latest Developments
Table 110. Beijing Tide Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 111. Beijing Tide Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 112. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Beijing Tide Pharmaceutical Main Business
Table 114. Beijing Tide Pharmaceutical Latest Developments
Table 115. Qilu Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 116. Qilu Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 117. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Qilu Pharmaceutical Main Business
Table 119. Qilu Pharmaceutical Latest Developments
Table 120. Shanghai Shyndec Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolios and Specifications
Table 122. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shanghai Shyndec Pharmaceutical Main Business
Table 124. Shanghai Shyndec Pharmaceutical Latest Developments
Table 125. Easton Biopharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 126. Easton Biopharmaceuticals Etoricoxib Product Portfolios and Specifications
Table 127. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Easton Biopharmaceuticals Main Business
Table 129. Easton Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Etoricoxib
Figure 2. Etoricoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etoricoxib Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Etoricoxib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Etoricoxib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 30 mg
Figure 10. Product Picture of 60 mg
Figure 11. Product Picture of 90 mg
Figure 12. Product Picture of 120 mg
Figure 13. Global Etoricoxib Sales Market Share by Type in 2022
Figure 14. Global Etoricoxib Revenue Market Share by Type (2018-2023)
Figure 15. Etoricoxib Consumed in Hospital
Figure 16. Global Etoricoxib Market: Hospital (2018-2023) & (K Units)
Figure 17. Etoricoxib Consumed in Pharmacy
Figure 18. Global Etoricoxib Market: Pharmacy (2018-2023) & (K Units)
Figure 19. Etoricoxib Consumed in Others
Figure 20. Global Etoricoxib Market: Others (2018-2023) & (K Units)
Figure 21. Global Etoricoxib Sales Market Share by Application (2022)
Figure 22. Global Etoricoxib Revenue Market Share by Application in 2022
Figure 23. Etoricoxib Sales Market by Company in 2022 (K Units)
Figure 24. Global Etoricoxib Sales Market Share by Company in 2022
Figure 25. Etoricoxib Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Etoricoxib Revenue Market Share by Company in 2022
Figure 27. Global Etoricoxib Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Etoricoxib Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Etoricoxib Sales 2018-2023 (K Units)
Figure 30. Americas Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 31. APAC Etoricoxib Sales 2018-2023 (K Units)
Figure 32. APAC Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 33. Europe Etoricoxib Sales 2018-2023 (K Units)
Figure 34. Europe Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Etoricoxib Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 37. Americas Etoricoxib Sales Market Share by Country in 2022
Figure 38. Americas Etoricoxib Revenue Market Share by Country in 2022
Figure 39. Americas Etoricoxib Sales Market Share by Type (2018-2023)
Figure 40. Americas Etoricoxib Sales Market Share by Application (2018-2023)
Figure 41. United States Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Etoricoxib Sales Market Share by Region in 2022
Figure 46. APAC Etoricoxib Revenue Market Share by Regions in 2022
Figure 47. APAC Etoricoxib Sales Market Share by Type (2018-2023)
Figure 48. APAC Etoricoxib Sales Market Share by Application (2018-2023)
Figure 49. China Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Etoricoxib Sales Market Share by Country in 2022
Figure 57. Europe Etoricoxib Revenue Market Share by Country in 2022
Figure 58. Europe Etoricoxib Sales Market Share by Type (2018-2023)
Figure 59. Europe Etoricoxib Sales Market Share by Application (2018-2023)
Figure 60. Germany Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Etoricoxib Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Etoricoxib Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Etoricoxib Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Etoricoxib Sales Market Share by Application (2018-2023)
Figure 69. Egypt Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Etoricoxib in 2022
Figure 75. Manufacturing Process Analysis of Etoricoxib
Figure 76. Industry Chain Structure of Etoricoxib
Figure 77. Channels of Distribution
Figure 78. Global Etoricoxib Sales Market Forecast by Region (2024-2029)
Figure 79. Global Etoricoxib Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Etoricoxib Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Etoricoxib Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Etoricoxib Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Etoricoxib Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Etoricoxib
Figure 2. Etoricoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etoricoxib Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Etoricoxib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Etoricoxib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 30 mg
Figure 10. Product Picture of 60 mg
Figure 11. Product Picture of 90 mg
Figure 12. Product Picture of 120 mg
Figure 13. Global Etoricoxib Sales Market Share by Type in 2022
Figure 14. Global Etoricoxib Revenue Market Share by Type (2018-2023)
Figure 15. Etoricoxib Consumed in Hospital
Figure 16. Global Etoricoxib Market: Hospital (2018-2023) & (K Units)
Figure 17. Etoricoxib Consumed in Pharmacy
Figure 18. Global Etoricoxib Market: Pharmacy (2018-2023) & (K Units)
Figure 19. Etoricoxib Consumed in Others
Figure 20. Global Etoricoxib Market: Others (2018-2023) & (K Units)
Figure 21. Global Etoricoxib Sales Market Share by Application (2022)
Figure 22. Global Etoricoxib Revenue Market Share by Application in 2022
Figure 23. Etoricoxib Sales Market by Company in 2022 (K Units)
Figure 24. Global Etoricoxib Sales Market Share by Company in 2022
Figure 25. Etoricoxib Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Etoricoxib Revenue Market Share by Company in 2022
Figure 27. Global Etoricoxib Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Etoricoxib Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Etoricoxib Sales 2018-2023 (K Units)
Figure 30. Americas Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 31. APAC Etoricoxib Sales 2018-2023 (K Units)
Figure 32. APAC Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 33. Europe Etoricoxib Sales 2018-2023 (K Units)
Figure 34. Europe Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Etoricoxib Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Etoricoxib Revenue 2018-2023 ($ Millions)
Figure 37. Americas Etoricoxib Sales Market Share by Country in 2022
Figure 38. Americas Etoricoxib Revenue Market Share by Country in 2022
Figure 39. Americas Etoricoxib Sales Market Share by Type (2018-2023)
Figure 40. Americas Etoricoxib Sales Market Share by Application (2018-2023)
Figure 41. United States Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Etoricoxib Sales Market Share by Region in 2022
Figure 46. APAC Etoricoxib Revenue Market Share by Regions in 2022
Figure 47. APAC Etoricoxib Sales Market Share by Type (2018-2023)
Figure 48. APAC Etoricoxib Sales Market Share by Application (2018-2023)
Figure 49. China Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Etoricoxib Sales Market Share by Country in 2022
Figure 57. Europe Etoricoxib Revenue Market Share by Country in 2022
Figure 58. Europe Etoricoxib Sales Market Share by Type (2018-2023)
Figure 59. Europe Etoricoxib Sales Market Share by Application (2018-2023)
Figure 60. Germany Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Etoricoxib Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Etoricoxib Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Etoricoxib Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Etoricoxib Sales Market Share by Application (2018-2023)
Figure 69. Egypt Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Etoricoxib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Etoricoxib in 2022
Figure 75. Manufacturing Process Analysis of Etoricoxib
Figure 76. Industry Chain Structure of Etoricoxib
Figure 77. Channels of Distribution
Figure 78. Global Etoricoxib Sales Market Forecast by Region (2024-2029)
Figure 79. Global Etoricoxib Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Etoricoxib Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Etoricoxib Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Etoricoxib Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Etoricoxib Revenue Market Share Forecast by Application (2024-2029)
